Newsfeeds - Spark Newswire

1 minute read

Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects

Today, 5:53 AM

Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.

BSX

2 minute read

Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum

By Benzinga Newsdesk

Today, 5:53 AM

The two drug-discovery projects for novel, next generation, innovative, patentable psychedelic compounds, are expected to expand Clearmind's IP portfolio Tel Aviv, Israel / Vancouver, Canada, Jan. 19, 2023

CMND

1 minute read

FDA
News

Israel-Based Clearmind Medicine Successfully Completes Production Of CMND-100 Drug Candidate For Clinical Trial

By Benzinga Newsdesk

Today, 5:53 AM

Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve

CMND

2 minute read

This Original Psychedelic-Based Obesity Treatment Set To First-In-Human Trials

By Lara Goldstein

Today, 5:53 AM

Psychedelics biopharma company Clearmind Medicine Inc. (NASDAQ: CMND) and clinical-stage firm SciSparc Ltd.

CMND

3 minute read

Israel-Based Clearmind Medicine Shows Efficacy Of Psychedelic Derived Obesity Treatment In Pre-Clinical Trial

By Benzinga Newsdesk

Today, 5:53 AM

In a series of pre-clinical trials, Clearmind's drug candidate MEAI significantly reduced body weight, improved fatty liver disease, and normalized insulin sensitivity Tel Aviv, Israel / Vancouver, Canada, Jan.

CMND

9 minute read

These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

By Lara Goldstein

Today, 5:53 AM

What a year for psychedelics!

ATAI

4 minute read

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK’s Research Support And More

By Lara Goldstein

Today, 5:53 AM

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

AWKNF

2 minute read

Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment

By Lara Goldstein

Today, 5:53 AM

Psychedelics company Clearmind Medicine Inc. (NASDAQ: CMND) aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for next-generation novel drug candidates, according to CEO Adi Zuloff-Shani.

CMND

3 minute read

Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 5:53 AM

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

AGYS

4 minute read

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More

By Lara Goldstein

Today, 5:53 AM

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

AWKNF